Influence of Dietary Chitosan Feeding Duration on Glucose and Lipid Metabolism in a Diabetic Rat Model.
Shing-Hwa LiuShih-An FengChen-Yuan ChiuMeng-Tsan ChiangPublished in: Molecules (Basel, Switzerland) (2021)
This study was designed to investigate the influence of dietary chitosan feeding-duration on glucose and lipid metabolism in diabetic rats induced by streptozotocin and nicotinamide [a non-insulin-dependent diabetes mellitus (NIDDM) model]. Male Sprague-Dawley rats were used as experimental animals and divided into short-term (6 weeks) and long-term (11 weeks) feeding durations, and each duration contained five groups: (1) control, (2) control + 5% chitosan, (3) diabetes, (4) diabetes + 0.8 mg/kg rosiglitazone (a positive control), and (5) diabetes + 5% chitosan. Whether the chitosan feeding was for 6 or 11 weeks, the chitosan supplementation decreased blood glucose and lipids levels and liver lipid accumulation. However, chitosan supplementation decreased plasma tumor necrosis factor (TNF)-α, insulin levels, alanine aminotransferase (ALT) activity, insulin resistance (HOMA-IR), and adipose tissue lipoprotein lipase activity. Meanwhile, it increased plasma high-density lipoproteins (HDL)-cholesterol level, plasma angiopoietin-like-4 protein expression, and plasma triglyceride levels (at 11-week feeding duration only). Taken together, 11-week (long-term) chitosan feeding may help to ameliorate the glucose and lipid metabolism in a NIDDM diabetic rat model.
Keyphrases
- drug delivery
- type diabetes
- glycemic control
- blood glucose
- wound healing
- insulin resistance
- hyaluronic acid
- adipose tissue
- diabetic rats
- cardiovascular disease
- high density
- rheumatoid arthritis
- high fat diet
- oxidative stress
- metabolic syndrome
- fatty acid
- blood pressure
- skeletal muscle
- polycystic ovary syndrome
- preterm birth
- low density lipoprotein